Emma Andrus, Associate Editor

Dermatology Times is recapping our top expert interviews from the month of January.

The 3-year partnership and collaboration will employ the use of generative artificial intelligence and analytics technologies.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Functional magnetic resonance imaging response was utilized to test motor, somatosensory association cortex, perception, and sensory integration processing in a recent study.

Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

The Centers for Medicare & Medicaid Services has issued a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum.

Marcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.

Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.

ICYMI, this week we had news about the completion of LEO Pharma's acquisition of Timber Pharmaceuticals, research pointing to melanoma overdiagnosis in White patients, artificial intelligence in skin cancer detection, and more.

A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.

A poster from Maui Derm Hawaii revealed an even more significant disparity than researchers anticipated.

Researchers from Pyeongchon, Korea, argue that evidence points to the need for a change in the terminology of "freckling," according to a poster from Maui Derm Hawaii.

A poster presented at Maui Derm Hawaii delved into the efficacy and safety of trifarotene 50µg/g cream in acne vulgaris and PIH.

Online patient recruitment methods were effective in a proof-of-concept trial involving patients with low-grade AK.

Click here to answer this week's poll.

Approximately half of patients presenting to dermatology clinics in Beirut reported the use of sunscreen.

The finalized acquisition comes 5 months after Timber Pharmaceuticals filed for chapter 11 bankruptcy.

Researchers also found that explainable AI methods, also known as XAI, further contributed to the confidence and accuracy associated with AI assistance.

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

In a recent study, prenatal opioid exposure was also linked to increased odds of infections and asthma, but not with allergies, anaphylaxis, orautoimmune conditions.

Keep up with the latest headlines in dermatology from the past week, including wildfire smoke associated with a spike in dermatology visits, microbiome research findings tied to skin aging, and more.

Among the many sessions to be held at the Maui Derm Hawaii 2024 conference on Maui, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll.

The study will evaluate the MRGPRX2 antagonist in healthy adults and adults with CSU.

This data builds upon data of the READY-1 and READY-2 trials, wherein relabotulinumtoxinA's duration of effect was validated.

SXRT may present a cost-effective and surgery-free therapeutic option for patients with non-aggressive BCC and SCC.

The study explored the potential role of hormonal changes, specifically estrogen levels, in the pathogenesis of rosacea.

The study suggests a relationship between an imbalance in the skin microbiota and LS-associated hypopigmentation.

A study found that combining dermoscopy with RCM not only improved diagnostic accuracy but also improved diagnostic certainty.

Factors such as nutritional compromise, low levels of vitamin D, and more, negatively affect bone metabolism in this patient population.